Your browser doesn't support javascript.
loading
Modulation of Autophagy Influences the Function and Survival of Human Pancreatic Beta Cells Under Endoplasmic Reticulum Stress Conditions and in Type 2 Diabetes.
Bugliani, M; Mossuto, S; Grano, F; Suleiman, M; Marselli, L; Boggi, U; De Simone, P; Eizirik, D L; Cnop, M; Marchetti, P; De Tata, V.
Afiliación
  • Bugliani M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Mossuto S; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Grano F; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Suleiman M; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Marselli L; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • Boggi U; Department of Surgical Pathology, Medicine, Molecular and Critical Area, University of Pisa, Pisa, Italy.
  • De Simone P; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
  • Eizirik DL; Medical Faculty, ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
  • Cnop M; Medical Faculty, ULB Center for Diabetes Research, Université Libre de Bruxelles, Brussels, Belgium.
  • Marchetti P; Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  • De Tata V; Department of Translational Research and New Technologies in Medicine and Surgery, University of Pisa, Pisa, Italy.
Article en En | MEDLINE | ID: mdl-30863363
ABSTRACT
Autophagy is the major mechanism involved in degradation and recycling of intracellular components, and its alterations have been proposed to cause beta cell dysfunction. In this study, we explored the effects of autophagy modulation in human islets under conditions associated to endoplasmic reticulum (ER) stress. Human pancreatic islets were isolated by enzymatic digestion and density gradient purification from pancreatic samples of non-diabetic (ND; n = 17; age 65 ± 21 years; gender 5 M/12 F; BMI 23.4 ± 3.3 kg/m2) and T2D (n = 9; age 76 ± 6 years; 4 M/5 F; gender BMI 25.4 ± 3.7 kg/m2) organ donors. Nine ND organ donors were treated for hypertension and 1 for both hypertension and hypercholesterolemia. T2D organ donors were treated with metformin (1), oral hypoglycemic agents (2), diet + oral hypoglycemic agents (3), insulin (3) or insulin plus metformin (3) as for antidiabetic therapy and, of these, 3 were treated also for hypertension and 6 for both hypertension and hypercholesterolemia. Two days after isolation, they were cultured for 1-5 days with 10 ng/ml rapamycin (autophagy inducer), 5 mM 3-methyladenine or 1.0 nM concanamycin-A (autophagy blockers), either in the presence or not of metabolic (0.5 mM palmitate) or chemical (0.1 ng/ml brefeldin A) ER stressors. In ND islets palmitate exposure induced a 4 to 5-fold increase of beta cell apoptosis, which was significantly prevented by rapamycin and exacerbated by 3-MA. Similar results were observed with brefeldin treatment. Glucose-stimulated insulin secretion from ND islets was reduced by palmitate (-40 to 50%) and brefeldin (-60 to 70%), and rapamycin counteracted palmitate, but not brefeldin, cytotoxic actions. Both palmitate and brefeldin induced PERK, CHOP and BiP gene expression, which was partially, but significantly prevented by rapamycin. With T2D islets, rapamycin alone reduced the amount of p62, an autophagy receptor that accumulates in cells when macroautophagy is inhibited. Compared to untreated T2D cells, rapamycin-exposed diabetic islets showed improved insulin secretion, reduced proportion of beta cells showing signs of apoptosis and better preserved insulin granules, mitochondria and ER ultrastructure; this was associated with significant reduction of PERK, CHOP and BiP gene expression. This study emphasizes the importance of autophagy modulation in human beta cell function and survival, particularly in situations of ER stress. Tuning autophagy could be a tool for beta cell protection.
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2019 Tipo del documento: Article País de afiliación: Italia

Texto completo: 1 Banco de datos: MEDLINE Idioma: En Revista: Front Endocrinol (Lausanne) Año: 2019 Tipo del documento: Article País de afiliación: Italia